116 related articles for article (PubMed ID: 36470678)
21. Reduction of relative centrifugation force within injectable platelet-rich-fibrin (PRF) concentrates advances patients' own inflammatory cells, platelets and growth factors: the first introduction to the low speed centrifugation concept.
Choukroun J; Ghanaati S
Eur J Trauma Emerg Surg; 2018 Feb; 44(1):87-95. PubMed ID: 28283682
[TBL] [Abstract][Full Text] [Related]
22. Platelet separation from whole blood in an aqueous two-phase system with water-soluble polymers.
Sumida E; Iwasaki Y; Akiyoshi K; Kasugai S
J Pharmacol Sci; 2006 May; 101(1):91-7. PubMed ID: 16717401
[TBL] [Abstract][Full Text] [Related]
23. Flow cytometry analysis of porcine platelets: optimized methods for best results.
Krajewski S; Kurz J; Wendel HP; Straub A
Platelets; 2012; 23(5):386-94. PubMed ID: 22035358
[TBL] [Abstract][Full Text] [Related]
24. Platelet removal by single-step centrifugation.
Rikkert LG; Coumans FAW; Hau CM; Terstappen LWMM; Nieuwland R
Platelets; 2021 May; 32(4):440-443. PubMed ID: 32552252
[TBL] [Abstract][Full Text] [Related]
25. Activation during preparation of therapeutic platelets affects deterioration during storage: a comparative flow cytometric study of different production methods.
Metcalfe P; Williamson LM; Reutelingsperger CP; Swann I; Ouwehand WH; Goodall AH
Br J Haematol; 1997 Jul; 98(1):86-95. PubMed ID: 9233569
[TBL] [Abstract][Full Text] [Related]
26. Comparison of platelet activation in platelet concentrates measured by flow cytometry or ADVIA 2120.
Beard MJ; Jeewa Z; Bashir S; Cardigan R; Thomas S
Vox Sang; 2011 Aug; 101(2):122-30. PubMed ID: 21492182
[TBL] [Abstract][Full Text] [Related]
27. A more efficient preparation system for HLA-eliminated platelets.
Hayashi T; Aminaka R; Fujimura Y; Koh Y; Sugaya S; Hayashi A; Ueno Y; Furuta RA; Tani Y; Takihara Y; Hirayama F
Vox Sang; 2020 Feb; 115(2):159-166. PubMed ID: 31769038
[TBL] [Abstract][Full Text] [Related]
28. Platelet aggregates as markers of platelet activation: characterization of flow cytometric method suitable for clinical applications.
Jy W; Horstman LL; Park H; Mao WW; Valant P; Ahn YS
Am J Hematol; 1998 Jan; 57(1):33-42. PubMed ID: 9423814
[TBL] [Abstract][Full Text] [Related]
29. Relationships between optical aggregometry (type born) and flow cytometry in evaluating ADP-induced platelet activation.
Sbrana S; Della Pina F; Rizza A; Buffa M; De Filippis R; Gianetti J; Clerico A
Cytometry B Clin Cytom; 2008 Jan; 74(1):30-9. PubMed ID: 17630652
[TBL] [Abstract][Full Text] [Related]
30. Isolation of Platelet-Derived Extracellular Vesicles.
Aatonen M; Valkonen S; Böing A; Yuana Y; Nieuwland R; Siljander P
Methods Mol Biol; 2017; 1545():177-188. PubMed ID: 27943214
[TBL] [Abstract][Full Text] [Related]
31. Relative and absolute changes of activated platelets, microparticles and platelet aggregates after activation in vitro.
Matzdorff AC; Berchner D; Kühnel G; Kemkes-Matthes B; Pralle H; Voss R
Haemostasis; 1998; 28(6):277-88. PubMed ID: 10461010
[TBL] [Abstract][Full Text] [Related]
32. Factors influencing platelet isolation: a prospective multicenter study from Western China.
Liu S; Yang G; Zeng G; Zhou X; Chen R; Chen B; Chen J; Wen X; Zhang X; Ren H; Zu R; Wang D; Leng P; Luo H
Platelets; 2023 Dec; 34(1):2194445. PubMed ID: 37041749
[TBL] [Abstract][Full Text] [Related]
33. Detection of circulating microparticles by flow cytometry: influence of centrifugation, filtration of buffer, and freezing.
Dey-Hazra E; Hertel B; Kirsch T; Woywodt A; Lovric S; Haller H; Haubitz M; Erdbruegger U
Vasc Health Risk Manag; 2010 Dec; 6():1125-33. PubMed ID: 21191433
[TBL] [Abstract][Full Text] [Related]
34. Effect of leukocyte filtration on the P-selectin expression of apheresis platelets.
Xie ZT; Chen C; Zhang SH; Yang HM; Tao ZH
Genet Mol Res; 2015 Jun; 14(2):5979-85. PubMed ID: 26125797
[TBL] [Abstract][Full Text] [Related]
35. Using six-colour flow cytometry to analyse the activation and interaction of platelets and leukocytes--A new assay suitable for bench and bedside conditions.
Granja T; Schad J; Schüssel P; Fischer C; Häberle H; Rosenberger P; Straub A
Thromb Res; 2015 Oct; 136(4):786-96. PubMed ID: 26281714
[TBL] [Abstract][Full Text] [Related]
36. Different Effects of Ranibizumab and Bevacizumab on Platelet Activation Profile.
Sobolewska B; Grimmel C; Gatsiou A; Sopova K; Klein J; Biedermann T; Stellos K; Ziemssen F
Ophthalmologica; 2015; 234(4):195-210. PubMed ID: 26305017
[TBL] [Abstract][Full Text] [Related]
37. Platelet microparticle membranes have 50- to 100-fold higher specific procoagulant activity than activated platelets.
Sinauridze EI; Kireev DA; Popenko NY; Pichugin AV; Panteleev MA; Krymskaya OV; Ataullakhanov FI
Thromb Haemost; 2007 Mar; 97(3):425-34. PubMed ID: 17334510
[TBL] [Abstract][Full Text] [Related]
38. Ultrastructural comparison of human platelets separated from blood by various means.
Zucker WH; Shermer RW; MAson RG
Am J Pathol; 1974 Nov; 77(2):255-67. PubMed ID: 4447129
[TBL] [Abstract][Full Text] [Related]
39. Multicolor flow cytometry for evaluation of platelet surface antigens and activation markers.
van Velzen JF; Laros-van Gorkom BA; Pop GA; van Heerde WL
Thromb Res; 2012 Jul; 130(1):92-8. PubMed ID: 22424855
[TBL] [Abstract][Full Text] [Related]
40. Comparison of platelet aggregability and P-selectin surface expression on platelets isolated by different methods.
Walkowiak B; Kralisz U; Michalec L; Majewska E; Koziolkiewicz W; Ligocka A; Cierniewski CS
Thromb Res; 2000 Sep; 99(5):495-502. PubMed ID: 10973680
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
